Myelodysplastic Syndromes (MDS) and Elderly Leukemia

Cancer Site Specific Teams develop comprehensive quality cancer care service from screening to survivorship for patients with cancer. Dr. Suman Kambhampati is the director for the MDS and Elderly Leukemia Site Team, having clinics at both KU Cancer Center and the Kansas City Veteran's Medical Center, a research lab and is the primary investigator on multiple clinical trials.

Clinial Trials

There are many clinical trials at the University of Kansas Cancer Center. Please select the links below to learn more.

Featured Trial:

• A phase Ib/IIb, open-label, multi-center study of oral Panobinostat (LBH589) administered with 5-Azacitidine (Vidaza) in adult patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) or acute myeloid leukemia (AML)
  • PI: Suman Kambhampati, MD
  • NCT00946647- Learn national information about this trial 

Other MDS/Elderly Leukemia Trials:

• MDS
• Leukemia, Other
• Leukemia, Not Specified
• Lymphoid Leukemia
• Myeloid and Monocytic Leukemia
• Clinical Trial Main Page

Support Groups

• Leukemia and Lymphoma Support Group
• Turning Point: Support for serious or chronic physical illness in the KC area
• Gilda's Club: Support for all cancers and stage
• Cancer Action: For programs and services of persons with cancer, their family, and friends